Skip to main content
William David Wells-Gatnik on Muck Rack

William David Wells-Gatnik

As seen in: MDPI, Taylor & Francis Online, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with William David

Contact William David, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Therapeutic barriers for headache management: issues facing the global north and global south in 2024

|
By William David Wells-Gatnik, Paolo Martelletti
| Taylor & Francis Online
KEYWORDS: Primary headaches global burden of diseases 2021 sustainable development goal 3 standard of care CGRP(r) therapies machine learning artificial intelligence 1. Introduction Primary headache disorders continue to contribute a disproportionate level of physical, economic, and psychosocial burden across the worldwide population.
Open in Who Shared Issue with article?

Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine

|
By William David Wells-Gatnik, Paolo Martelletti, Lanfranco Pellesi
| Taylor & Francis Online
ABSTRACT Introduction Rimegepant and atogepant, two innovative oral medications for the treatment of migraine, are gaining prominence in the treatment of migraine. However, outside of specialist headache centers, these novel medications remain subjectively underutilized. While multiple rationales exist describing their underutilization, a leading factor is the complexity and clinical flexibility attributed to the individual members of the gepant medication class.
Open in Who Shared View Duplicates (2) Issue with article?

Gepants in the acute management of migraine

|
By William David Wells-Gatnik, Paolo Martelletti
| Future Medicine Verified
• None The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates . 23(1), 34 ( ).Medline • None Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019 . 21(1), 1–3 ( ).Medline • None European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update .
Open in Who Shared Issue with article?
See all 6 licensed articles (7 Total)